Crescita Therapeutics (TSE:CTX) Trading Up 1.8% – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX) was up 1.8% during trading on Monday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 3,525 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 5,882 shares. The stock had previously closed at C$0.57.

Crescita Therapeutics Price Performance

The firm has a market capitalization of C$11.24 million, a PE ratio of -3.87 and a beta of 1.69. The business has a 50-day moving average of C$0.58 and a 200 day moving average of C$0.59. The company has a current ratio of 3.37, a quick ratio of 2.29 and a debt-to-equity ratio of 6.02.

Insider Buying and Selling at Crescita Therapeutics

In other Crescita Therapeutics news, Director Jose Darocha acquired 86,000 shares of Crescita Therapeutics stock in a transaction on Friday, December 27th. The stock was purchased at an average price of C$0.60 per share, for a total transaction of C$51,436.60. Corporate insiders own 10.87% of the company’s stock.

About Crescita Therapeutics

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.